Skip to main content
Log in

Adverse reactions to practolol in hospitalized patients

A report from the Boston collaborative drug surveillance program

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Adverse reactions to practolol were studied in 198 prospectively monitored hospitalized medical patients. The mean age of the practolol recipients was 57 years; angina and cardiac arrhythmias were the most common indications for therapy. Adverse reactions were attributed to practolol in 20 patients (10%). Fifteen of these twenty reactions involved impairment of cardiac function (bradyarrhythmias, heart block, congestive heart failure, hypotension), and in three instances the reaction was considered life-threatening. Three additional patients had cutaneous reactions attributed to the drug. Adverse reactions to practolol were not dose-related, but toxicity appeared to be more frequent among patients concurrently receiving quinidine. The frequency of cardiovascular complications of propranolol in a similar series of patients was nearly identical. However, no skin reactions were attributed to propranolol. The findings suggest that practolol and propranolol produce unwanted cardiovascular effects with nearly equal frequency among hospitalized patients. Cutaneous reactions to practolol are evident even during short-term use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arndt, K.A., Jick, H.: Rates of cutaneous reactions to drugs: a report from the Boston Collaborative Drug Surveillance Program. J. Amer. Med. Ass.235, 918–923 (1976)

    Google Scholar 

  • Barrett, A.M.: The pharmacology of practolol. Postgrad. Med. J.47 (Suppl), 7–12 (Jan, 1971)

    Google Scholar 

  • Brown, P., Baddeley, H., Read, A.E., Davies, J.D., McGarry, J.: Sclerosing peritonitis, an unusual reaction to a β-adrenergic blocking drug (practolol). Lancet1974 II, 1477–1481

    Google Scholar 

  • Dunlop, D., and Shanks, R.G.: Selective blockade of adrenoceptive beta receptors in the heart. Brit. J. Pharmacol.32, 201–218 (1968)

    Google Scholar 

  • Feliz, R.H., Ive, F.A., Dahl, M.G.C.: Cutaneous and ocular reactions to practolol. Brit. Med. J.1974/4, 321–324

    Google Scholar 

  • Goldstein, R.E.: A comparison of beta-blocking agents. Circulation47, 443–445 (1973)

    Google Scholar 

  • Goldstein, R.E., Hall, R.A., Epstein, S.E.: Comparison of relative inotropic and chronotropic effects of propranolol, practolol, and sotalol. Chest64, 619–627 (1973)

    Google Scholar 

  • Greenblatt, D.J., Koch-Weser, J.: Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. Amer. Heart J.86, 478–484 (1973)

    Google Scholar 

  • Greenblatt, D.J., Koch-Weser, J.: Adverse reactions to β-adrenergic receptor blocking drugs: a report from the Boston Collaborative Drug Surveillance Program. Drugs7, 118–129 (1974)

    Google Scholar 

  • Improvement in prognosis of myocardial infarction by long-term use of beta-adrenoceptor blockade using practolol: a multicentre international study. Brit. Med. J.1975/3, 735–740

  • Jensen, H.E., Mikkelsen, H.I., Wadskov, S., Sondergaard, J.: Cutaneous reactions to propranolol (Inderal). Acta Med. Scand.199, 363 (1976)

    Google Scholar 

  • Jick, H.: Drugs-remarkably nontoxic. New Engl. J. Med.291, 824–828 (1974)

    Google Scholar 

  • Liang, C.-S., Hood, W.B.: The myocardial depressant effect of beta-receptor blocking agents. Circulat. Res.35, 272–280 (1974)

    Google Scholar 

  • Miller, R.R.: Drug surveillance utilizing epidemiologic methods: a report from the Boston Collaborative Drug Surveillance Program. Amer. J. Hosp. Pharm.30, 584–592 (1973)

    Google Scholar 

  • Miller, R.R., Greenblatt, D.J.: Drug Effects in Hospitalized Patients: Experiences of the Boston Collaborative Drug Surveillance Program, 1966–1975. New York: John Wiley and Sons 1976

    Google Scholar 

  • Raftery, E.B., Denman, A.M.: Systemic lupus erythematosus syndrome induced by practolol. Brit. Med. J.1973/2, 252–255

    Google Scholar 

  • Waal-Manning, H.J.: Problems with practolol. Drugs10, 336–341 (1975)

    Google Scholar 

  • Wright, P.: Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Brit. Med. J.1975/1, 595–598

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfeifer, H.J., Greenblatt, D.J. & Koch-Weser, J. Adverse reactions to practolol in hospitalized patients. Eur J Clin Pharmacol 12, 167–170 (1977). https://doi.org/10.1007/BF00609854

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00609854

Key words

Navigation